Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TEM

Tempus AI Inc.

Sep 17 • 04:00PM ET

49.23

Dollar change -5.44
Percentage change -9.95	%

Healthcare • Health Information Services • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: ARKK ARKG VTI ONEQ VB FPX VXF VBR VBK VTWO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	66.98%	Shs Outstand	154.32M	Perf Week	9.28%
Market Cap	7.60B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	50.96M	Perf Month	-3.24%
Income	-	PEG	-	EPS next Q	-0.27	Inst Own	17.60%	Short Float	6.97%	Perf Quarter	34.95%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	2.90	Perf Half Y	-
Book/sh	0.64	P/B	77.25	EPS next Y	-	ROA	-	Short Interest	3.55M	Perf Year	-
Cash/sh	3.18	P/C	15.50	EPS next 5Y	-	ROE	-	52W Range	22.89 - 77.00	Perf YTD	22.31%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-36.06%	Beta	-
Dividend TTM	-	Quick Ratio	3.52	Sales past 5Y	-	Gross Margin	-	52W Low	115.07%	ATR (14)	6.71
Dividend Ex-Date	Jul 18, 2006	Current Ratio	3.70	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	48.26	Volatility	12.58% 15.67%
Employees	-	Debt/Eq	4.84	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.22	Target Price	46.00
Option/Short	Yes / Yes	LT Debt/Eq	4.78	EPS Q/Q	-803.73%	Payout	-	Rel Volume	1.63	Prev Close	54.67
Sales Surprise	3.54%	EPS Surprise	82.24%	Sales Q/Q	126.39%	Earnings	Aug 06 AMC	Avg Volume	1.22M	Price	49.23
SMA20	-12.30%	SMA50	5.45%	SMA200	13.52%	Trades		Volume	1,997,122	Change	-9.95%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48
Jul-09-24	Initiated	JP Morgan	Overweight	$42
Jul-09-24	Initiated	BofA Securities	Buy	$41

Sep-16-24 03:09PM	Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating (Investor's Business Daily) +10.71%
Sep-13-24 08:30AM	Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024 (Business Wire) +8.65%
Sep-12-24 08:30AM	Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients (Business Wire)
Sep-11-24 10:15AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Sep-04-24 08:30AM	Tempus Announces Real World Data Collaboration with BioNTech (Business Wire)
10:30AM	Loading…
Aug-30-24 10:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Aug-28-24 08:30AM	Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire) -13.49%
Aug-27-24 11:40AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) +13.15%
Aug-21-24 06:13PM	Why Tempus AI Stock Skyrocketed Nearly 22% Today (Motley Fool) +21.73% -9.71%
09:07AM	Is Tempus AI Inc (NASDAQ:TEM) The Best Small-Cap AI Stock to Buy? (Insider Monkey)
01:11AM	BerGenBio Second Quarter Results 2024: Solid clinical and financial progress (PR Newswire)
Aug-18-24 12:00PM	3 Stocks for the AI Age (InvestorPlace)
Aug-16-24 08:30AM	Personalis and Tempus Announce Expanded Collaboration (Business Wire) +7.80%
Aug-14-24 09:50AM	Examining the Role of AI in Advancing Healthcare Efficiency (PR Newswire)
Aug-08-24 12:16PM	Cathie Wood's Ark Invest is buying the dip on tech stocks (Yahoo Finance Video)
08:30AM	Loading…
08:30AM	NPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational Assay (Business Wire)
06:20AM	7 Growth Stocks That Could 7X in the Next 7 Years (InvestorPlace)
Aug-06-24 04:42PM	Tempus: Q2 Earnings Snapshot (Associated Press Finance) +6.36%
04:01PM	Tempus Reports Second Quarter 2024 Results (Business Wire)
10:15AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
06:30AM	3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns (InvestorPlace)
Aug-02-24 09:55AM	What Makes Tempus AI (TEM) an Attractive Investment? (Insider Monkey)
06:43AM	3 AI-Powered Healthcare Stocks Transforming Medicine (InvestorPlace)
06:30AM	7 New Growth Stock Listings That Can Be Long-Term Wealth Creators (InvestorPlace)
Aug-01-24 08:30AM	Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2 (Business Wire) -9.24%
Jul-30-24 08:30AM	Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics (Business Wire)
Jul-29-24 04:30PM	3 AI-in-Healthcare Stocks to Buy for Outsized Returns (InvestorPlace)
Jul-26-24 06:07AM	7 Growth Stocks That Can Create Millionaires by 2030 (InvestorPlace)
Jul-18-24 10:30AM	7 Millionaire-Making Growth Stocks to Buy and Forget (InvestorPlace)
08:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
09:30AM	Loading…
Jul-17-24 09:30AM	Tempus to Report Second Quarter 2024 Financial Results on August 6 (Business Wire)
Jul-16-24 09:30AM	Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests (Business Wire) +11.31%
08:15AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jul-15-24 09:29PM	3 Under-the-Radar IPO Stocks to Buy Before They Double (InvestorPlace) -7.95%
Jul-10-24 09:30AM	Tempus Surpasses 500 Research Publications (Business Wire)
Jul-09-24 02:26PM	Why Wall Street Is Bullish on Healthcare Tech Stock Tempus AI (Investopedia)
10:16AM	Wall Street analysts bullish on genetic testing firm Tempus AI (Reuters)
09:35AM	Tempus AI initiated, Helios downgraded: Wall Street's top analyst calls (The Fly)
Jul-08-24 09:30AM	American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM (Business Wire) +7.51%
Jul-05-24 07:45AM	IPO Watch: 3 New Stocks Worth a Strong Look (InvestorPlace) -10.21%
Jul-04-24 03:49PM	3 New IPOs That Could Be the Next Big Thing (InvestorPlace)
Jul-02-24 09:30AM	CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test (Business Wire) +7.92%
Jul-01-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
Jun-26-24 09:30AM	Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib (Business Wire) +10.42%
Jun-25-24 09:30AM	Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension (Business Wire)
Jun-14-24 06:16PM	Musk pay package, cruise line pressures: Market Domination (Yahoo Finance Video)
03:57PM	Tempus AI stock rises after Nasdaq debut via IPO (Yahoo Finance Video)
Jun-13-24 06:44PM	Tempus Announces Pricing of Initial Public Offering (Business Wire)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tempus AI, Inc.	10% Owner	Aug 16 '24	Buy	5.07	3,500,000	17,745,000	12,718,800	Aug 20 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TEM

Tempus AI Inc.

Upgrade your FINVIZ experience